621 Down-regulated Mir-23A Contributes to Invasion and Metastasis of Cutaneous Melanoma by Promoting Autophagy
Q. Shi,H. Wang,W. Guo,Y. Yang,W. Zhang,S. Guo,T. Zhao,L. Liu,Z. Jian,Q. Luan,G. Wang,T. Gao,C. Li
DOI: https://doi.org/10.1016/j.jid.2016.02.661
IF: 7.59
2016-01-01
Journal of Investigative Dermatology
Abstract:Since the progression of melanoma from primary stage to advanced stage leads to a precipitous drop in the patients’ survival, the mechanisms underlying this process are of great importance. Recently, autophagy has been implicated in modulating cancer invasion and metastasis, and the level of autophagy has been found dysregulated in melanoma. Here, we reported miR-23a as a novel autophagy-regulating microRNA that played a remarkable role in modulating melanoma invasive and metastatic capacity. We found that serum miR-23a level was significantly down-regulated in melanoma patients and highly correlated with poor clinical outcomes. Notably, tissue miR-23a level was drastically decreased in metastatic melanoma compared with that in primary melanoma and melanocytic nevus. Furthermore, ectopic miR-23a expression prevented the invasion-metastasis cascade of melanoma both in vitro and in vivo, and overexpressed miR-23a suppressed the invasive and migratory property of melanoma by abrogating autophagy through directly targeting ATG12. Specially, attenuated melanoma invasion and migration mediated by overexpressed miR-23a resulted from the inhibition on ROS-HIF1α-RhoE signaling. Finally, we revealed that the down-regulation of miR-23a in metastatic melanoma was caused by RUNX2 in a transcriptional repression-manner. Taken together, our findings demonstrate that miR-23a can act as a crucial epigenetic repressor of melanoma invasion and metastasis in an autophagy-dependent way, which indicates that miR-23a-mediated autophagy inhibition can be exploited to restrain invasion-metastasis cascade in melanoma treatment.